Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Early Phase 1
1(33.3%)
3Total
N/A(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04352244Recruiting

The Physiology of Human Brown Adipose Tissue

Role: collaborator

NCT06067555Early Phase 1Recruiting

Intradermal Influenza Vaccination

Role: collaborator

NCT05561933Not ApplicableCompleted

Scaling Well-Being for Educators During COVID-19

Role: collaborator

NCT04426318Not ApplicableCompleted

COVID-19 and the Healthy Minds Program for Educators

Role: collaborator

NCT04904692Active Not Recruiting

Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

Role: collaborator

All 5 trials loaded